NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Retatrutide from Peptide-S? Mail in a sample (US only) and let us test it.

Test my supply
+8 more ↓
69%
Finnrick rating
#367 of 419 Retatrutide vendors
30 of 45 classifiable tests passed
customers 4.6★ (18)
methodology · Purity focus
Finnrick analysis · Retatrutide

Peptide-S Retatrutide is held down by repeated purity/fill misses and three identity failures, one as recent as Aug 2026. A later 99.9% near-exact-fill result improves the trajectory but does not erase the mixed record.

methodology →
vendor intelligence report
Vendor Intelligence Report: Peptide-S

Corporate and platform records leave the legal seller unresolved while a Shop910 tenant trail anchors the storefront. The dossier also tests the COA gallery, flypay checkout, messaging-channel split and inactive ad footprint.

37 pages7 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.05
90%
9
2
Tirzepatide
$0.39
85%
41
3
Semaglutide
$0.72
70%
6
5
Retatrutideselected
$1.00
69%
46
6
Mazdutide
$1.80
65%
4
7
Survodutide
$3.30
60%
4
8
BPC-157
-
52%
5
10
Tesamorelin
$1.80
46%
9
11
Sermorelin
-
37%
3
12
KPV
-
-
0
14
PT-141
-
-
0
15
SS-31
-
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%11 Jun 2025: 56%11 Jun 2025: 53%13 Jun 2025: 55%30 Jun 2025: 54%30 Jun 2025: 51%30 Jun 2025: 53%3 Jul 2025: 55%16 Jul 2025: 52%16 Jul 2025: 49%25 Jul 2025: 52%25 Jul 2025: 54%25 Jul 2025: 56%25 Jul 2025: 58%25 Jul 2025: 55%3 Aug 2025: 53%4 Aug 2025: 55%4 Aug 2025: 52%4 Aug 2025: 54%11 Aug 2025: 56%12 Aug 2025: 58%21 Aug 2025: 60%31 Aug 2025: 61%4 Sep 2025: 60%4 Sep 2025: 61%4 Sep 2025: 62%9 Sep 2025: 63%18 Sep 2025: 62%30 Sep 2025: 63%13 Oct 2025: 62%24 Oct 2025: 63%4 Nov 2025: 64%17 Nov 2025: 62%16 Dec 2025: 63%1 Jan 2026: 64%7 Jan 2026: 65%26 Jan 2026: 66%26 Jan 2026: 67%10 Feb 2026: 68%15 Feb 2026: 69%22 Feb 2026: 67%10 Mar 2026: 68%3 Aug 2026: 69%9 Aug 2026: 67%9 Aug 2026: 68%5 Oct 2026: 69%15 Nov 2026: current 69%56%63%69%Jun 25Nov 26
Showing Retatrutide tests only
Peptide testing

Ordered Retatrutide from Peptide-S? Mail in a sample (US only) and let us test it.

Test my supply
Peptide-S Retatrutide test history
COA-backed lab tests
1-10 of 46

About Peptide-S test results from Finnrick

Peptide-S is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 11 peptides and 135 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Peptide-S peptides in this dataset are BPC-157 (5 tests), Cagrilintide (4 tests) and GHK-Cu (9 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 135 recent tests. It also includes 2 corrections related to this vendor.

Corrections
2025-08-01
Concerning results
Peptide-S Mazdutide results are being reviewed, will be updated soon.
2025-08-01
Concerning results
Peptide-S Survodutide results are being reviewed, will be updated soon.
Peptide testing

Ordered Retatrutide from Peptide-S? Mail in a sample (US only) and let us test it.

Test my supply